AbSci Corp (ABSI): Price and Financial Metrics


AbSci Corp (ABSI): $3.50

-0.03 (-0.85%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add ABSI to Watchlist
Sign Up

Industry: Biotech


Ranked

of

in industry

ABSI Stock Price Chart Interactive Chart >

Price chart for ABSI

ABSI Price/Volume Stats

Current price $3.50 52-week high $31.53
Prev. close $3.53 52-week low $3.32
Day low $3.39 Volume 402,700
Day high $3.74 Avg. volume 1,146,472
50-day MA $6.69 Dividend yield N/A
200-day MA $10.58 Market Cap 324.98M

AbSci Corp (ABSI) Company Bio


Absci Corporation, an AI-powered synthetic biology company, offers biologic drug candidates and production cell lines using integrated drug creation platform for partners in the United States. Its integrated drug creation platform enables the creation of biologics by unifying the drug discovery and cell line development processes into one process. The company was founded in 2011 and is headquartered in Vancouver, Washington.


ABSI Latest News Stream


Event/Time News Detail
Loading, please wait...

ABSI Latest Social Stream


Loading social stream, please wait...

View Full ABSI Social Stream

Latest ABSI News From Around the Web

Below are the latest news stories about Absci Corp that investors may wish to consider to help them evaluate ABSI as an investment opportunity.

Absci to Participate in Upcoming Investor Conferences

VANCOUVER, Wash., Feb. 17, 2022 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), the drug and target discovery company harnessing deep learning AI and synthetic biology to expand the therapeutic potential of proteins, today announced the company will be participating virtually in the following investor conferences. Truist Life Sciences AI Symposium – Biotech & ToolsPanel Discussion on Tuesday, March 1st at 7:10 a.m. Pacific Time / 10:10 a.m. Eastern TimeInterested parties may view the Sympo

Yahoo | February 17, 2022

Future Outlook And Stock Price Performance For Absci Corporation (NASDAQ: ABSI)

In the last trading session, 1.42 million shares of the Absci Corporation (NASDAQ:ABSI) were traded. Most recently the company’s share price was $8.83, and it changed around $0.05 or 0.57% from the last close, which brings the market valuation of the company to $799.73M. ABSI currently trades at a discount to its 52-week high of … Future Outlook And Stock Price Performance For Absci Corporation (NASDAQ: ABSI) Read More »

Marketing Sentinel | February 16, 2022

Absci to Participate in the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference

VANCOUVER, Wash., Feb. 11, 2022 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), the drug and target discovery company harnessing deep learning AI and synthetic biology to expand the therapeutic potential of proteins, today announced the company will be participating virtually in the upcoming BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference.

GlobeNewswire | February 11, 2022

Absci (ABSI) Presents At 40th Annual J.P. Morgan Virtual Healthcare Conference

The following slide deck was published by Absci Corporation in conjunction with this event.

Seeking Alpha | January 12, 2022

Biotech Stock Roundup: BIIB's AD Drug Update, AMGN's Drug Approval & Other Updates

Regulatory and other pipeline updates from Biogen (BIIB) and AMGN are among a few key highlights from the biotech sector during the past week.

Yahoo | January 12, 2022

Read More 'ABSI' Stories Here

ABSI Price Returns

1-mo -51.19%
3-mo N/A
6-mo -67.44%
1-year N/A
3-year N/A
5-year N/A
YTD -57.32%
2021 N/A
2020 N/A
2019 N/A
2018 N/A
2017 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.6527 seconds.